ARGNF:OTCMKTS
argenx SE
790,15 US$
0,00%
(0,00) 1K
13-okt, 10:39:58 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoARGNF tikeri uchun statistika yaratilmoqda...
Bozor kapitali
53,14 mlrd
Oʻrtacha hajm
14,00
Hajmi
0,00
52 haftalik eng yuqori
1 020,00 US$
52 haftalik eng past
708,72 US$
Beta
0,46
Muomaladagi aksiyalar
62,89 mln
Xodimlar soni
2 ming
Bozor kapitali
53,14 mlrd
Oʻrtacha hajm
14,00
Hajmi
0,00
52 haftalik eng yuqori
1 020,00 US$
52 haftalik eng past
708,72 US$
Beta
0,46
Muomaladagi aksiyalar
62,89 mln
Xodimlar soni
2 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
26 daqiqa oldin
argenx sets October 22 results date as Argenx stock costs EUR 761.20
ad-hoc-news.de
·
3 soat oldin
argenx schedules third-quarter results for October 22: stock pre-market at EUR 756.30
Investing.com South Africa
·
19 soat oldin
Argenx shares may move 5.5% on earnings release next week By Investing.com
TipRanks
·
1 kun oldin
argenx Schedules Q3 2026 Results Call and Business Update
Profil
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
argenx SE haqida